NCT01967550 Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA) Status COMPLETED Phase PHASE3
NCT01965353 A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01954693 A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis Status UNKNOWN Phase PHASE2
NCT01948960 Influence of Exceptional Patient Characteristics on Everolimus Exposure Status COMPLETED Phase PHASE4
NCT01934894 Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases Status TERMINATED Phase PHASE2
NCT01922492 Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug. Status UNKNOWN Phase NA
NCT01914484 Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT01911871 Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations Status COMPLETED Phase N/A
NCT01908556 Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) Status UNKNOWN Phase PHASE4
NCT01902992 Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch Status COMPLETED Phase PHASE3
NCT01895049 Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria Status COMPLETED Phase PHASE4
NCT01893372 Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT01892644 Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome Status WITHDRAWN Phase PHASE2
NCT01889420 Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT01886287 P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome Status TERMINATED Phase PHASE2
NCT01885247 4-10 Week Observational Study Comparing 3 Management Strategies for Obstructive Chronic BronchoPneumopathy (OCBP) in Common Clinical Practice Status UNKNOWN Phase N/A